Cochlear origin of hearing loss in MELAS syndrome

Annals of Neurology

Volumn 43, Issue 3, 1998, Pages 350-359

  Sue, C M ^a   Lipsett, L J ^a   Crimmins, D S ^a   Tsang, C S ^b   Boyages, S C ^c   Presgrave, C M ^a   Gibson, W P R ^a   Byrne, E ^d   Morris, J G L ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COCHLEA PROSTHESIS; ELECTROCOCHLEOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GENETIC LINKAGE; HUMAN; MALE; MELAS SYNDROME; NERVE STIMULATION; PERCEPTION DEAFNESS; POINT MUTATION; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SCHOOL CHILD;

ADOLESCENT; ADULT; AUDIOMETRY, EVOKED RESPONSE; AUDIOMETRY, PURE-TONE; CHILD; COCHLEA; ELECTRIC STIMULATION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; HEARING DISORDERS; HUMANS; MALE; MELAS SYNDROME; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PEDIGREE; VESTIBULOCOCHLEAR NERVE;

EID: 0031914941     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430313     Document Type: Article

References (44)

1. Petty RKH, Harding AE, Morgan-Hughes JA. The clinical features of mitochondrial myopathy. Brain 1986;109:915-938
2. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-488
3. Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4kb mitochondrial DNA deletion. Nat Genet 1992;1:11-15
4. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992;1:368-371
5. Leu(UUR) gene. Diabetes 1994;43:746-751
6. Leu(UUR) mutation. Neurology 1993;43:1015-1020
7. Berenberg RA, Pellock JM, DiMauro S, et al. Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol 1977;1:37-54
8. Berkovic SF, Carpenter S, Evans A, et al. Myoclonus epilepsy and ragged-red fibres (MERRF): I. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 1989;112:1231-1260
9. Crimmins D, Morris JGL, Walker GL, et al. Mitochondrial encephalomyopathy: variable clinical expression within a single kindred. J Neurol Neurosurg Psychiatry 1993;56:900-905
10. Sue CM, Holmes-Walker DJ, Morris JGL, et al. Mitochondrial gene mutations and diabetes mellitus. Lancet 1993;1:437-438
11. Kotsimbos N, Jean-François MJB, Huizing M, et al. Rapid and noninvasive screening of patients with mitochondrial myopathy. Hum Mutat 1994;4:132-135
12. Macrae J. Monoaural tables for determining percentage loss of hearing. In: Macrae J, ed. NAL Report 118. Sydney: National Acoustic Laboratories, 1988;17-25
13. Travers A. AB Word list, National Acoustic Laboratories protocols. Victoria, 1990
14. Chiappa KH. Brainstem auditory evoked potentials: Methodology. In: Chiappa KH, ed. Evoked potentials in clinical medicine. New York: Raven Press, 1990;173-221
15. Gibson WPR. Electrocochleography (ECochG). In: Gibson WPR, ed. Essentials of clinical electric response audiometry. Edinburgh: Churchill Livingstone, 1978;59-106
16. Gibson WPR, Kaufman Arenberg I. Electrocochleography (ECoG) in the electrophysiologic diagnosis of endolymphatic hydtops. In: Kaufman Arenburg I, ed. Dizziness and balance disorders. Amsterdam: Kugler Publications, 1993;477-485
17. Gibson WPR, Prasher DK, Kilkenny GP. The clinical significance of transtympanic electrocochleography in the diagnosis of Meniere's disorder. Ann Otol 1983;92:155-159
18. Gibson WPR. The role of electrocochleography in the understanding of the pathophysiology of Meniere's disease. Auris Nasus Larynx 1996;23:S12-S17
19. Kemp DT. Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 1978;64:1386-1391
20. Collet L, Gartner M, Moulin A, et al. Evoked otoacoustic emissions and sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 1989;115:1060-1062
21. Martin WH, Schwegler JW, Gleeson AL, Shi YB. New techniques of hearing assessment. [Review]. Otolaryngol Clin North Am 1994;27:487-510
22. Moulin A, Bera J-C, Collet L. Distortion product otoacoustic emissions and sensorineural hearing loss. Audiology 1994;33: 305-326
23. White KR, Culpepper B, Maxon AB, et al. Transient evoked otoacoustic emissions. Int J Pediatr Otorhinolaryngol 1995;29: 203-217
24. Yellin MW, Jerger J, Fifer RC. Norms for disproportionate loss in speech intelligibility. Ear Hear 1989;10:231-234
25. Gibson WPR. Electrocochleography: a comparison of clicks versus tone bursts in the diagnosis of endolymphatic hydrops. In: Kaufman Arenburg I, ed. Proceedings of the Third International Symposium and Workshops on the Surgery of the Inner Ear. Amsterdam: Kugler Publications, 1991:281-285
26. Lonsbury-Martin BL, Harris FP, Stagner BB, et al. Distortion product emissions in humans: I. Basic properties in normally hearing subjects. Ann Otol Rhinol Laryngol 1990;Suppl 147:3-14
27. Nelson DA, Kimberley BP. Distortion-product emissions and auditory sensitivity in human ears with normal hearing and cochlear hearing loss. J Speech Hear Res 1992;35:1142-1159
28. Smurzynski J, Kim DO. Distortion-product and click-evoked otoacoustic emissions of normally-hearing adults. Hear Res 1992;58:227-240
29. Elverland HH, Torbergsen T. Audiologic findings in a family with mitochondtial disorder. Am J Otol 1991;12:459-465
30. Oshima T, Ueda N, Ikeda K, et al. Bilateral sensorineural hearing loss associated with the point mutation in mitochondrial genome. Laryngoscope 1996;106:43-48
31. Leu(UUR) gene. Laryngoscope 1996;106:49-53
32. Harding AE. The other genome [editorial]. BMJ 1991;303: 377-379
33. Johns DJ. Mitochondrial DNA and disease. N Engl J Med 1995;333:638-644
34. Sue CM, Crimmins DS, Quigley A, et al. Detection of MELAS point mutation 3243 in muscle, blood, and hair follicles. J Clin Neurosci 1996;3:403
35. Pickles JO. Introduction to the physiology of hearing. London: Academic Press, 1982
36. Da Cruz MJ. Quantification of the fundamental mechanisms leading to cochlear hearing loss. Nedlands: Universiry of Western Australia, 1994
37. Fernandez C, Hinojosa R. Postnatal development of endocochlear potential and stria vascularis in the cat. Acta Otolaryngol (Stockh) 1974;78:173-186
38. + -ATPase in gerbil cochlea. J Histochem Cytochem 1989;37:127-134
39. Iinuma T. Evaluation of adenosine triphosphatase activity in the stria vascularis and spiral ligament of normal guinea pigs. Laryngoscope 1967;77:141-158
40. Tasaki I, Spyropoulos CS. Stria vascularis as source of endocochlear potential. J Neurophysiol 1959;22:149-155
41. Offner FF, Dallos P, Cheatham MA. Positive endocochlear potential: mechanism of production by marginal cells of stria vascularis. Hear Res 1987;29:117-124
42. + -ATPase in normal and ischemic porcine myocardium. J Mol Cell Cardiol 1990;22:1071-1082
43. Lindsay JR, Hinojosa R. Histopathologic features of the inner ear associated with Kearns-Sayre syndrome. Arch Otolaryngol 1976;102:747-752
44. Steel KP, Bock GR. Genetic factots affecting hearing development. Acta Otolaryngol (Stockh) 1985;(Suppl 421):48-56